Insurance and geographic variations in non-invasive prenatal testing.
作者信息
Ellison Jacqueline, Wang Catharine, Yarrington Christina, Connors Philip, Hanchate Amresh
机构信息
Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island, USA.
Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts, USA.
出版信息
Prenat Diagn. 2022 Jul;42(8):1004-1007. doi: 10.1002/pd.6155. Epub 2022 May 1.
Abstract
摘要
相似文献
1
Insurance and geographic variations in non-invasive prenatal testing.无创产前检测中的保险与地域差异。
Prenat Diagn. 2022 Jul;42(8):1004-1007. doi: 10.1002/pd.6155. Epub 2022 May 1.
2
Implementation of non-invasive prenatal testing by semiconductor sequencing in a genetic laboratory.在基因实验室中通过半导体测序实施无创产前检测
Prenat Diagn. 2016 Aug;36(8):699-707. doi: 10.1002/pd.4841. Epub 2016 Jul 1.
3
Study of the extent of information desired by women undergoing non-invasive prenatal testing following positive prenatal Down-syndrome screening test results.对唐氏综合征产前筛查结果呈阳性后接受无创产前检测的女性所需信息程度的研究。
Int J Gynaecol Obstet. 2017 Jun;137(3):338-339. doi: 10.1002/ijgo.12146. Epub 2017 Mar 28.
4
Trisomy 21 DNA test (MaterniT21) for detecting Down syndrome in the first trimester.孕早期用于检测唐氏综合征的21三体DNA检测（MaterniT21）。
Manag Care. 2012 Apr;21(4):19-20.
5
Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing.使用拷贝数变异测序对中国 3429 例羊水穿刺样本进行前瞻性染色体分析。
Am J Obstet Gynecol. 2018 Sep;219(3):287.e1-287.e18. doi: 10.1016/j.ajog.2018.05.030. Epub 2018 May 29.
6
Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screening.无创产前检测：游离胎儿DNA在唐氏综合征筛查中的应用
Br J Gen Pract. 2017 Jul;67(660):298-299. doi: 10.3399/bjgp17X691625.
7
Non-invasive prenatal testing: what are we missing?无创产前检测：我们遗漏了什么？
Ultrasound Obstet Gynecol. 2021 Feb;57(2):345-346. doi: 10.1002/uog.22005.
8
[Non-invasive prenatal screening].[无创产前筛查]
Rev Prat. 2019 Feb;69(2):e55.
9
Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.1995 - 2005年南澳大利亚州引入孕早期联合唐氏综合征筛查后，基于州/人口的唐氏综合征筛查及侵入性产前检测趋势
Am J Obstet Gynecol. 2007 Apr;196(4):315.e1-7; discussion 285-6. doi: 10.1016/j.ajog.2007.01.037.
10
[Non-invasive prenatal testing is a breakthrough in prenatal screening].无创产前检测是产前筛查领域的一项突破。
Ugeskr Laeger. 2015 Jul 6;177(28).
引用本文的文献
1
Comparing the Introduction and Implementation of Noninvasive Prenatal Testing (NIPT) in Japan, the Netherlands, and the United States: An Integrative Review.日本、荷兰和美国无创产前检测（NIPT）的引入与实施比较：一项综合综述
Prenat Diagn. 2025 Jan 15. doi: 10.1002/pd.6708.
2
Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds.力求让来自不同祖先背景的个人从基因组学进展中获得公平的益处。
Am J Hum Genet. 2024 May 2;111(5):809-824. doi: 10.1016/j.ajhg.2024.04.002. Epub 2024 Apr 19.
3
Patient experiences with prenatal cell-free DNA screening in a safety net setting.患者在安全网环境下对产前无细胞 DNA 筛查的体验。
Prenat Diagn. 2024 Apr;44(4):409-417. doi: 10.1002/pd.6541. Epub 2024 Feb 29.
本文引用的文献
1
Addressing bias and disparities in periviable counseling and care.解决可存活期咨询与护理中的偏见和差异问题。
Semin Perinatol. 2022 Apr;46(3):151524. doi: 10.1016/j.semperi.2021.151524. Epub 2021 Nov 9.
2
Evaluating for disparities in prenatal genetic counseling.评估产前遗传咨询中的差异。
Am J Obstet Gynecol MFM. 2022 Jan;4(1):100494. doi: 10.1016/j.ajogmf.2021.100494. Epub 2021 Sep 25.
3
Non-invasive prenatal test uptake in socioeconomically disadvantaged neighborhoods.社会经济条件不利社区的无创性产前检测普及率。
Prenat Diagn. 2021 Oct;41(11):1395-1400. doi: 10.1002/pd.6043. Epub 2021 Sep 14.
4
Racial and ethnic differences in uptake of cell-free fetal DNA aneuploidy screening in an urban safety net hospital.城市安全网医院中游离胎儿DNA非整倍体筛查接受情况的种族和民族差异
Prenat Diagn. 2021 Oct;41(11):1389-1394. doi: 10.1002/pd.6029. Epub 2021 Aug 19.
5
The impact of insurance on equitable access to non-invasive prenatal screening (NIPT): private insurance may not pay.保险对无创产前筛查（NIPT）公平可及性的影响：私人保险可能不予支付。
J Community Genet. 2021 Jan;12(1):185-197. doi: 10.1007/s12687-020-00498-w. Epub 2021 Jan 6.
6
Social and Structural Determinants of Health Inequities in Maternal Health.孕产妇健康不平等的社会和结构决定因素。
J Womens Health (Larchmt). 2021 Feb;30(2):230-235. doi: 10.1089/jwh.2020.8882. Epub 2020 Nov 12.
7
Information and power: Women of color's experiences interacting with health care providers in pregnancy and birth.信息与权力：有色人种女性在妊娠和分娩期间与医疗保健提供者互动的体验。
Soc Sci Med. 2019 Oct;238:112491. doi: 10.1016/j.socscimed.2019.112491. Epub 2019 Aug 12.
8
Cell-free DNA for the detection of fetal aneuploidy.游离胎儿 DNA 检测用于胎儿非整倍体检测。
Fertil Steril. 2018 Feb;109(2):195-200. doi: 10.1016/j.fertnstert.2017.12.019.
9
Prenatal diagnosis and socioeconomic status in the non-invasive prenatal testing era: A population-based study.无创产前检测时代的产前诊断与社会经济地位：一项基于人群的研究
Aust N Z J Obstet Gynaecol. 2018 Aug;58(4):404-410. doi: 10.1111/ajo.12778. Epub 2018 Jan 30.
10
Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis.羊膜穿刺术和绒毛取样术后与操作相关的流产风险：一项系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2015 Jan;45(1):16-26. doi: 10.1002/uog.14636.
Zotero 插件